CPHICHINA PHARMA HOLDINGS, INC.vs its industry peers
A metric-by-metric comparison of CHINA PHARMA HOLDINGS, INC. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPHIEsta | $31M#8 | — | 0.9x#5 | 7.5x#6 | -8.5%#5 | 32.7%#4 | -78.2%#2 | -8.8%#2 | -7.7%#1 | 5#1 | -61.2%#7 | — |
| CELU | $37M#1 | — | — | 1.4x#4 | -51.0%#7 | -58.4%#9 | -230.9%#3 | — | -398.1%#6 | — | — | — |
| CRVO | $37M#2 | 0.0x#1 | 1.6x#8 | 9.2x#7 | -58.9%#8 | -65.6%#11 | -706.2%#7 | -117.5%#9 | -5165.9%#7 | — | — | — |
| CNTX | $34M#3 | — | 0.9x#6 | — | — | -35.2%#8 | — | -94.6%#6 | — | — | — | — |
| LITS | $34M#4 | — | 0.6x#4 | — | -100.0%#10 | -189.7%#13 | — | -28.1%#4 | — | — | -62.4%#8 | — |
| FLNA | $33M#5 | — | 0.5x#2 | 0.8x#2 | 277.6%#1 | -273.7%#14 | -232.0%#4 | -133.5%#11 | — | — | — | — |
| RMTI | $32M#6 | 267.0x#3 | 0.9x#7 | 0.5x#1 | -31.8%#6 | -1007.1%#16 | -6.8%#1 | -15.1%#3 | -14.0%#3 | 4#2 | — | — |
| BRNS | $31M#7 | — | 0.5x#3 | — | -100.0%#10 | -8.8%#6 | — | -116.4%#8 | — | — | -37.0%#3 | — |
| KYNB | $31M#9 | 0.2x#2 | — | 4.8x#5 | -78.3%#9 | 485.6%#1 | -712.7%#8 | — | — | — | -37.9%#4 | — |
| RNAZ | $31M#10 | — | — | — | — | -106.9%#12 | — | — | — | — | -83.9%#10 | — |
| MIRA | $30M#11 | — | 3.7x#11 | — | — | -33.0%#7 | — | -127.9%#10 | — | — | -45.1%#6 | — |
| HEPA | $29M#12 | — | 22.4x#13 | — | — | 37.3%#3 | — | -647.5%#13 | — | — | -17.6%#2 | — |
| APUS | $3M#16 | — | 0.0x#1 | — | — | -331.7%#15 | — | -5.6%#1 | -11.2%#2 | — | -90.1%#11 | — |
| ABVC | $28M#13 | — | 2.7x#10 | 93.2x#9 | 0.0%#3 | -61.3%#10 | -2416.0%#9 | -76.9%#5 | -68.5%#4 | — | -63.6%#9 | — |
| IGC | $28M#14 | — | 4.5x#12 | 21.7x#8 | -5.5%#4 | 45.2%#2 | -585.8%#6 | -116.1%#7 | -125.5%#5 | 3#3 | -38.4%#5 | — |
| NXTC | $27M#15 | — | 2.3x#9 | 1.2x#3 | 252.6%#2 | -0.3%#5 | -257.5%#5 | -459.7%#12 | — | — | 4.6%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice